Fig. 1From: Naringenin alters the pharmacokinetics of ranolazine in part through the inhibition of cytochrome P450 (3A4) and P-glycoproteinIn the presence and absence of naringenin and verapamil, the transfer of ranolazine from the serosal to mucosal side of the chick-everted ileum (n = 6). R stands for ranolazine, N for naringenin, and MDS is for multidose studyBack to article page